Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (Nasdaq: OCEA) is a Providence, Rhode Island-based biopharmaceutical company that completed its de-SPAC business combination with Aesther Healthcare Acquisition Corp. in February 2023. Aesther Healthcare Acquisition Corp., sponsored by Aesther Healthcare Sponsor LLC, conducted its IPO in 2021 targeting the healthcare sector. The 8-K filed February 7, 2023 pertains to the closing of that merger, bringing Ocean Biomedical's pipeline — which spans oncology, pulmonary fibrosis, and infectious disease therapeutic candidates — onto public markets under the OCEA ticker on Nasdaq. The company emerged from Brown University research and has pursued multiple clinical-stage programs since listing. Sign up at SpacDesk for full filings, deal timelines, and sponsor data on OCEA and thousands of other SPAC transactions.